Consolidated Statements of Assets and Liabilities - USD ($) $ in Thousands	Sep. 30, 2025		Dec. 31, 2024
ASSETS
Investments at fair value:	$ 434,267	[1]	$ 423,430	[2]
Cash and cash equivalents	26,174		42,218
Interest receivable	5,214		3,831
Unrealized appreciation on foreign currency forward contracts	21,663		0
Receivable for investments sold	87		55
Total assets	487,405		469,534
LIABILITIES
Collateral payable on forward currency exchange contracts	330		160
Management fees payable	778		751
Income incentive fee payable	3,803		5,221
Unrealized depreciation on foreign currency forward contracts	0		26,106
Accrued expenses and other liabilities	909		1,006
Total liabilities	5,820		33,244
Commitments and contingencies (Note 7)
NET ASSETS
Common shares, $0.01 par value (44,724,135 and 44,724,135 shares issued and outstanding at September 30, 2025 and December 31, 2024, respectively)	447		447
Additional paid in capital	459,283		459,283
Distributable earnings (loss)	21,855		(23,440)
Total net assets	481,585		436,290
Total liabilities and net assets	$ 487,405		$ 469,534
Net asset value per share (in dollars per share)	$ 10.77		$ 9.76

[1] (1)Unless otherwise indicated, issuers of debt investments held by the Company (which such term “Company” shall include the Company’s subsidiaries for purposes of this Schedule of Investments) are denominated in dollars. All debt investments are income producing unless otherwise indicated.

[2] Unless otherwise indicated, issuers of debt investments held by the Company (which such term “Company” shall include the Company’s subsidiaries for purposes of this Schedule of Investments) are denominated in dollars. All debt investments are income producing unless otherwise indicated.